M2spine registry – preliminary results from a multidisciplinary, multicenter registry to assess the quality of life of patients with multiple myeloma and vertebral column lesions von Hubertus, V., Buhre, C., von Bronewski, E.J., Miller, H., Früh, A., Keller, U., Blau, I.W., Acker, G., Vajkoczy, P., Onken, J.S.

Volltext

Clinical course and outcome of multiple myeloma patients undergoing surgery for vertebral column lesions – results from a cohort of 704 patients of the European M2spine study group... von Hubertus, V., Viezens, L., Stangenberg, M., Liang, R., Kramer, A., Orban, C., Kerschbaumer, J., Kunze, B., Telera, S., Früh, A., Miller, H., Entenmann, C.J., Keller, T., Kaul, D., Krönke, J., Blau, I.W., Keller, U., Ringel, F., Thomé, C., Meyer, H.S., Dreimann, M., Meyer, B., Vajkoczy, P., Onken, J.S.

Volltext

A phase I/IIa study of the human CD38 antibody MOR202 (MOR03087) in relapsed or refractory multiple myeloma von Raab, M.S, Chatterjee, M, Goldschmidt, H, Agis, H, Blau, I.W, Einsele, H, Engelhardt, M, Ferstl, B, Gramatzki, M, Röllig, C, Weisel, K, Klöpfer, P, Weinelt, D, Härtle, S, Peschel, C

Volltext

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma von Mai, E K, Bertsch, U, Dürig, J, Kunz, C, Haenel, M, Blau, I W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M S, Neben, K, Lindemann, H-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I G H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Volltext

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial von Penack, O., Schwartz, S., Martus, P., Reinwald, M., Schmidt-Hieber, M., Thiel, E., Blau, I. W.

Volltext

Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management von Penack, O., Rempf, P., Graf, B., Blau, I. W., Thiel, E.

Volltext

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients von Kiehl, M.G, Schäfer-Eckart, K, Kröger, M, Bornhäuser, M, Basara, N, Blau, I.W, Kienast, J, Fauser, A.A, Ehninger, G, Armstrong, V.W, Shipkova, M

Volltext

Factors contributing to delayed surgery in multiple myeloma vertebral column lesions von Hubertus, V., Buhre, C., Nissimov, N., Stangenberg, M., Viezens, L., Meyer, H., Keller, T., Kaul, D., Habbel, P., I.W., Blau, Keller, U., Meyer, B., Dreimann, M., Vajkoczy, P., Onken, J.S.

Volltext

Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion von Schmidt-Hieber, Martin, Schwarck, S., Stroux, A., Ganepola, S., Reinke, P., Thiel, E., Uharek, L., Blau, I. W.

Volltext

Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients von Erdmann, J.-H., Graf, B., Blau, I.W., Fischer, F., Timm, G., Hemmati, P., Arnold, R., Penack, O.

Volltext

Phase III trial of bortezomib, cyclophosphamide and dexamethasone in newly diagnosed myeloma von Mai, E.K, Bertsch, U, Durig, J, Kunz, C, Haenel, M, Blau, I.W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M.S, Neben, K, Lindemann, H.-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I.G.H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Volltext

Prophylactic i.v. Igs in patients with a high risk for CMV after allo-SCT von Schmidt-Hieber, M, Schwarck, S, Stroux, A, Thiel, E, Ganepola, S, Uharek, L, Blau, I W

Volltext

Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures von Penack, O., Rempf, P., Eisenblätter, M., Stroux, A., Wagner, J., Thiel, E., Blau, I. W.

Volltext

Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation von Ringdén, O., Remberger, M., Runde, V., Bornhäuser, M., Blau, I.W., Basara, N., Hölig, K., Beelen, D.W., Hägglund, H., Basu, O., Ehninger, G., Fauser, A.A.

Volltext

PF597 HIGH DOSE MELPHALAN (200MG/M2) AND AUTOLOGOUS TRANSPLANTATION IN NEWLY‐DIAGNOSED MULTIPLE MYELOMA UP TO THE AGE OF 70 YEARS: A SUBGROUP ANALYSIS FROM THE PHASE III GMMG‐MM5 T... von Mai, E.K., Miah, K., Merz, M., Dürig, J., Scheid, C., Weisel, K.C., Kunz, C., Bertsch, U., Munder, M., Lindemann, H.‐W., Hose, D., Jauch, A., Seckinger, A., Luntz, S., Sauer, S., Fuhrmann, S., Brossart, P., Elmaagacli, A., Goerner, M., Bernhard, H., Hoffmann, M., Raab, M.S., Blau, I.W., Hänel, M., Benner, A., Salwender, H.J., Goldschmidt, H.

Volltext

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic haematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an internationa... von Ruutu, T, Beelen, D, Finke, J, Holowiecki, J, Uharek, L, Kienast, J, Larsson, K, Zander, A.R, Gramatzki, M, Einsele, H, Volin, L, Trenschel, R, Schnitzler, M, Giebel, S, Blau, I.W, Stelljes, M, Repp, R, Stuhler, G, Freund, M, Casper, J

Volltext

First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HD... von Sonneveld, P., van der Holt, B., Schmidt-Wolf, I.G.H., Bertsch, U., Jarari, L. el, Salwender, Hans-Jürgen, Zweegman, S., Vellenga, E., Schubert, J., Blau, I.W., Jie, GSK, Beverloo, B., Jauch, A., Hose, D., Schaafsma, R., Kersten, M.J., Delforge, M., de Weerdt, O., van der Griend, R., Wijermans, P.W., Martin, Hans, van der Velde, H., Lokhorst, Henk M., Goldschmidt, H.

Volltext

Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Wor... von Penack, O., Tridello, G., Salmenniemi, U., Martino, R., Khanna, N., Perruccio, K., Fagioli, F., Richert-Przygonska, M., Labussière-Wallet, H., Maertens, J., Jubert, C., Aljurf, M., Pichler, H., Krivan, G., Kunadt, D., Popova, M., Gabriel, M., Calore, E., Blau, I.W., Benedetti, F., Itäla-Remes, M., Kort, E. de, Russo, D., Faraci, M., Ménard, A.L., Borne, P. von dem, Poiré, X., Yesilipek, A., Gozdzik, J., Yegin, Z.A., Yañez, L., Facchini, L., Gorkom, G. van, Thurner, L., Kocak, U., Sampol, A., Zuckerman, T., Bierings, M., Mielke, S., Ciceri, F., Wendel, L., Knelange, N., Mikulska, M., Averbuch, D., Styczynski, J., Camara, R. de la, Cesaroaq, S.

Volltext bestellen

Stem cell mobilization in multiple myeloma patients: Do we need an age-adjusted regimen for the elderly? von Fietz, T., Rieger, K., Dimeo, F., Blau, I.W., Thiel, E., Knauf, W.U.

Volltext

Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors von Blau, I.W, Schmidt-Hieber, M, Basara, N, Hopfenmüller, W, Bischoff, M, Günzelmann, S, Kirsten, D, Schmetzer, B, Roemer, E, Kiehl, M.G, Thiel, E, Fauser, A.A

Volltext